Author Correction: Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy.

Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
31 Jan 2020
Historique:
entrez: 2 2 2020
pubmed: 2 2 2020
medline: 2 2 2020
Statut: epublish

Résumé

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiants

DOI: 10.1038/s41598-020-58486-6 PMID: 32005869 PMC: PMC6994718
pubmed: 32005869
doi: 10.1038/s41598-020-58486-6
pii: 10.1038/s41598-020-58486-6
pmc: PMC6994718
doi:

Types de publication

Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

1918

Commentaires et corrections

Type : ErratumFor

Auteurs

Annamaria Ruzzo (A)

Department of Biomolecular Sciences, Università degli Studi di Urbino "Carlo Bo", Urbino, Italy. annamaria.ruzzo@uniurb.it.
ORCID: 0000-0003-2815-1890

Francesco Graziano (F)

Azienda Ospedaliera "Ospedali Riuniti Marche Nord", Pesaro, Italy. graziano.fda@yahoo.com.

Francesca Galli (F)

Laboratory of Methodology for Clinical research, Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy.

Fabio Galli (F)

Laboratory of Methodology for Clinical research, Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy.

Eliana Rulli (E)

Laboratory of Methodology for Clinical research, Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy.
ORCID: 0000-0003-1058-4137

Sara Lonardi (S)

Istituto Oncologico Veneto IOV - IRCCS, Padova, Italy.

Monica Ronzoni (M)

Ospedale San Raffaele, Milano, Italy.

Bruno Massidda (B)

Azienda Ospedaliera Universitaria di Cagliari, P.O. Monserrato, Monserrato, Italy.

Vittorina Zagonel (V)

Istituto Oncologico Veneto IOV - IRCCS, Padova, Italy.

Nicoletta Pella (N)

Azienda Ospedaliera S. Maria della Misericordia, Udine, Italy.

Claudia Mucciarini (C)

Ospedale "B. Ramazzini", Carpi, Italy.

Roberto Labianca (R)

Ospedale Papa Giovanni XXIII, Bergamo, Italy.

Maria Teresa Ionta (MT)

Azienda Ospedaliera Universitaria di Cagliari, P.O. Monserrato, Monserrato, Italy.

Irene Bagaloni (I)

Department of Biomolecular Sciences, Università degli Studi di Urbino "Carlo Bo", Urbino, Italy.

Enzo Veltri (E)

Ospedale di Gaeta ASL Latina, Gaeta, Italy.

Pietro Sozzi (P)

Ospedale degli Infermi di Biella, Biella, Italy.

Sandro Barni (S)

Ospedale "Treviglio-Caravaggio", Treviglio, Italy.

Vincenzo Ricci (V)

Ospedale San Raffaele, Milano, Italy.

Luisa Foltran (L)

Azienda Ospedaliera Santa Maria degli Angeli, Pordenone, Italy.

Mario Nicolini (M)

Azienda Ospedaliera Ospedale "Cervesi", Cattolica, Italy.

Edoardo Biondi (E)

Ospedale "F. Renzetti", Lanciano, Italy.

Annalisa Bramati (A)

Azienda Ospedaliera Fatebenefratelli, Milano, Italy.

Daniele Turci (D)

AUSL Ospedale di Ravenna, Ravenna, Italy.

Silvia Lazzarelli (S)

Azienda Ospedaliera di Cremona, Cremona, Italy.

Claudio Verusio (C)

Ospedale di Saronno, Saronno, Italy.

Francesca Bergamo (F)

Istituto Oncologico Veneto IOV - IRCCS, Padova, Italy.

Alberto Sobrero (A)

Azienda Ospedaliera "Ospedale San Martino", Genova, Italy.

Luciano Frontini (L)

Fondazione GISCAD, Vanzago, Italy.

Mauro Magnani (M)

Department of Biomolecular Sciences, Università degli Studi di Urbino "Carlo Bo", Urbino, Italy.

Classifications MeSH